hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
Sunday 2 August 2015
Novavax (NVAX) Announces Seasonal Influenza VLP Met Immunogenicity Targets in ... - StreetInsider.com
Novavax (NVAX) Announces Seasonal Influenza VLP Met Immunogenicity Targets in ... - StreetInsider.com
INFLUENZA - GOOGLE NEWS | 30 JULY 2015
http://pulse.me/s/4pZqRU
Novavax (NVAX) Announces Seasonal Influenza VLP Met Immunogenicity Targets in ...StreetInsider.comNovavax (NASDAQ: NVAX) ... Read more
Posted by Rob Lambkin-Williams
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment